x
Filter:
Filters applied
- Oncology
Publication Date
Please choose a date range between 2016 and 2020.
Author
- Boorjian, Stephen A11
- Thompson, R Houston10
- Andriole, Gerald L9
- Kim, Eric H8
- Leibovich, Bradley C8
- Vetter, Joel M8
- Daneshmand, Siamak7
- Shetty, Anup S7
- Djaladat, Hooman6
- Lepor, Herbert6
- Abel, E Jason5
- Briganti, Alberto5
- Carver, Brett S5
- Allaf, Mohamad E4
- Campbell, Steven C4
- Freedland, Stephen J4
- Kutikov, Alexander4
- Lane, Brian R4
- Master, Viraj A4
- Anderson, Christopher B3
- Assel, Melissa3
- Cooperberg, Matthew R3
- Liss, Michael A3
- Syed, Jamil S3
- Allen, Glenn O2
Keyword
- acute kidney injury1
- AKI1
- American Society of Anesthesiology1
- ASA1
- CHF1
- chronic obstructive pulmonary disease1
- CI1
- confidence interval1
- congestive heart failure1
- COPD1
- CPT1
- current procedural erminology1
- HTN1
- hypertension1
- interquartile range1
- IQR1
- length of stay1
- LOS1
- National Surgical Quality Improvement Program1
- NMIBC1
- NSQIP1
- OR1
- RF1
- TURBT1
- UTI1
Oncology
276 Results
- Oncology
Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance Cohort
UrologyVol. 138p91–97Published online: December 30, 2019- Justin R. Gregg
- John W. Davis
- Chad Reichard
- Xuemei Wang
- Mary Achim
- Brian F. Chapin
- and others
Cited in Scopus: 3To report biopsy-related and oncologic outcomes in a large prospective active surveillance cohort that was initiated in the premagnetic resonance imaging era and to additionally identify clinical factors associated with disease reclassification in order to inform future studies designed to improve enrollment and follow-up on active surveillance. - Oncology
Risk Factors for Infection after Prostate Biopsy in the United States
UrologyVol. 138p113–118Published online: December 30, 2019- Jonathan E. Shoag
- Christopher Gaffney
- Morgan Pantuck
- Tianyi Sun
- Michael Gorin
- Edward Schaeffer
- and others
Cited in Scopus: 5We used the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked data from 2001 to 2015 and recorded 30-day infection rates and emergency department, hospital and, intensive care unit (ICU) admissions. We performed adjusted analyses to analyze the effect of age, demographic data, surgeon volume, rectal swab use, and biopsy year on infections. - Oncology
Transrectal Subharmonic Ultrasound Imaging for Prostate Cancer Detection
UrologyVol. 138p106–112Published online: December 30, 2019- I. Gupta
- B. Freid
- V. Masarapu
- P. Machado
- E. Trabulsi
- K. Wallace
- and others
Cited in Scopus: 6To assess the prostate cancer (CaP) detection rates of contrast-enhanced, transrectal subharmonic ultrasound imaging (SHI). - Health Services Research
Urinary Diversion Disparity Following Radical Cystectomy for Bladder Cancer in the Hispanic Population
UrologyVol. 137p66–71Published online: December 26, 2019- Emily M. Rios
- Mitchell A. Parma
- Roman A. Fernandez
- Timothy N. Clinton
- Ryan M. Reyes
- Dharam Kaushik
- and others
Cited in Scopus: 1To determine if disparities in quality of surgical care exist between Hispanics and non-Hispanics undergoing radical cystectomy for bladder cancer. - Oncology
DaBlaCa-11: Photodynamic Diagnosis in Flexible Cystoscopy—A Randomized Study With Focus on Recurrence
UrologyVol. 137p91–96Published online: December 13, 2019- Ditte Drejer
- Anne-Louise Moltke
- Anna Munk Nielsen
- Gitte W. Lam
- Jørgen Bjerggaard Jensen
Cited in Scopus: 9To examine whether photodynamic diagnosis (PDD) in addition to flexible cystoscopy in the outpatient clinic can reduce risk of tumor recurrence in patients with previous nonmuscle invasive bladder cancer. PDD is an optical technique that enhances the visibility of pathologic tissue and helps guidance tumor resection. - Oncology
Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria
UrologyVol. 138p60–68Published online: December 10, 2019- Zachary A. Hamilton
- Umberto Capitanio
- Deepak Pruthi
- Fady Ghali
- Alessandro Larcher
- Devin N. Patel
- and others
Cited in Scopus: 12To investigate risk factors for and outcomes in pathological T3a-upstaging in Renal Cell Carcinoma (RCC), as Tumor-Node-Metastasis staging for T3a RCC was recently revised. - Oncology
Prostate Cancer Nonascitic Peritoneal Carcinomatosis After Robot-assisted Laparoscopic Radical Prostatectomy: 3 Case Reports and Review of the Literature
UrologyVol. 137p121–125Published online: December 5, 2019- Verane Achard
- Gilles Achard
- Alex Friedlaender
- Arnaud Roth
- Jean-Christophe Tille
- Raymond Miralbell
- and others
Cited in Scopus: 9Robot-assisted laparoscopic radical prostatectomy is one of the treatment options for localized prostate cancer, with an excellent disease control rate. However, these patients can experience late disease recurrence with metastatic dissemination. Peritoneal metastases are an uncommon recurrence site. Here, we discuss 3 cases of peritoneal metastases following robot-assisted laparoscopic radical prostatectomy and the mechanisms of peritoneal invasion. Through a literature review and our case reports, we postulate the existence of 2 distinct mechanisms of peritoneal invasion: one being iatrogenic, following a laparoscopic surgery with a well differentiated prostate cancer at a nonadvanced stage of the disease, the other involving the natural course of poor-prognosis tumors, even without surgery. - Oncology
The Association of Urologic Oncology Fellowship Training and Diagnostic Yield of Prostate Biopsy
UrologyVol. 137p115–120Published online: November 27, 2019- Molly E. DeWitt-Foy
- Eric A. Klein
- Ahmed ElShafei
- W. Melissa Coronado
- Steven Campbell
- Michael Gong
- and others
Cited in Scopus: 1To determine the relationship between urologic oncology fellowship training (UOFT) and diagnostic yield of prostate biopsy. - Oncology
How Many Cores Should be Obtained During Saturation Biopsy in the Era of Multiparametric Magnetic Resonance? Experience in 875 Patients Submitted to Repeat Prostate Biopsy
UrologyVol. 137p133–137Published online: November 20, 2019- Pietro Pepe
- Michele Pennisi
- Filippo Fraggetta
Cited in Scopus: 16To evaluate the number of needle cores combined with multiparametric magnetic resonance imaging (mpMRI) findings needed to diagnose all clinically significant cases of prostate cancer (csPCa) in men subject to transperineal saturation biopsy (SPBx; 30 cores). - Oncology
Diagnostic Properties of Total and Free Prostate-Specific Antigen to Predict Overall and Clinically Significant Prostate Cancer Among Men With Low Testosterone and Prior Negative Biopsy
UrologyVol. 137p97–101Published online: November 13, 2019- Logan S. Schwarzman
- Rodrigo L. Pagani
- Samuel J. Ohlander
- Mahmoud Mima
- Michael R. Abern
- Gerald L. Andriole
- and others
Cited in Scopus: 4To evaluate whether total serum PSA, free-PSA ratio and PSA density have similar diagnostic properties for detecting prostate cancer (PCa) and clinically-significant (cs) PCa in men with normal testosterone compared to men with low testosterone with a prior negative biopsy. - OncologyOpen Access
Clinical Anatomy of the Puboprostatic Ligament for the Safe Guidance for the Prostate Surgery
UrologyVol. 136p190–195Published online: November 12, 2019- Hyun-Min Choi
- So-Young Jung
- Soo-Jung Kim
- Hee-Jun Yang
- Jang-Hwan Kim
- Young-Tae Kim
- and others
Cited in Scopus: 1To provide the anatomy of the puboprostatic ligament and related structures to save urogenital competence after prostatectomy. - Oncology
The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-Year Institutional Experience
UrologyVol. 136p169–175Published online: November 11, 2019- Andrew W. Silagy
- Roy Mano
- Kyle A. Blum
- Renzo G. DiNatale
- Julian Marcon
- Satish K. Tickoo
- and others
Cited in Scopus: 6To assess which patients respond best following cytoreductive nephrectomy for renal cell carcinoma (RCC) with sarcomatoid dedifferentiation (sRCC) and whether outcomes are improving over time. - Oncology
Redefining the Concept of Clinically Insignificant Prostate Cancer
UrologyVol. 136p176–179Published online: November 9, 2019- Daisy E. Frankcombe
- Jian Li
- Ronald J. Cohen
Cited in Scopus: 4To assess the risk of biochemical recurrence (BCR) in small low-grade prostate tumors following radical prostatectomy (RP), which are defined as clinically insignificant based on the existing criteria developed by Stamey and Epstein. - Oncology
Prostatic Ductal Adenocarcinoma Controlled for Cancer Grade and Tumor Volume Does Not Have an Independent Effect on Adverse Radical Prostatectomy Outcomes Compared to Usual Acinar Prostatic Adenocarcinoma
UrologyVol. 137p108–114Published online: November 8, 2019- Oleksii A. Iakymenko
- Isabella Lugo
- Deukwoo Kwon
- Wei Zhao
- Amin Hayee
- Sanoj Punnen
- and others
Cited in Scopus: 8To study if prostatic ductal adenocarcinoma (PDA) controlled by Grade Group (GG), PSA, and tumor volume (TV) is an independent predictor of adverse radical prostatectomy (RP) outcomes. - Oncology
UK Multicenter Prospective Evaluation of the Leibovich Score in Localized Renal Cell Carcinoma: Performance has Altered Over Time
UrologyVol. 136p162–168Published online: November 6, 2019- Naveen S. Vasudev
- Michelle Hutchinson
- Sebastian Trainor
- Roisean Ferguson
- Selina Bhattarai
- Adebanji Adeyoju
- and others
Cited in Scopus: 7To examine changes in outcome by the Leibovich score using contemporary and historic cohorts of patients presenting with renal cell carcinoma (RCC) - Oncology
Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered a “Negative Core” in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis
UrologyVol. 137p102–107Published online: November 6, 2019- Joon Yau Leong
- Jaime O. Herrera-Caceres
- Hanan Goldberg
- Elwin Tham
- Seth Teplitsky
- Leonard G. Gomella
- and others
Cited in Scopus: 0To assess the impact of excluding Gleason Grade Group 1 (GG1) prostate cancer (CaP) cores from current pre-radical prostatectomy (RP) nomograms. - Oncology
Ten-Year Treatment Outcomes of Radical Prostatectomy Vs External Beam Radiation Therapy Vs Brachytherapy for 1503 Patients With Intermediate-risk Prostate Cancer
UrologyVol. 136p180–189Published online: November 5, 2019- Barry W. Goy
- Raoul Burchette
- Margaret S. Soper
- Tangel Chang
- Harry A. Cosmatos
Cited in Scopus: 19To compare 10-year oncologic treatment outcomes of radical prostatectomy (RP) vs external beam radiation therapy (EBRT) vs brachytherapy (BT) for patients with intermediate-risk prostate cancer (IRPC). - Oncology
Percutaneous Image-guided Core Needle Biopsy for Upper Tract Urothelial Carcinoma
UrologyVol. 135p95–100Published online: October 23, 2019- Jason P. Joseph
- Theodora A. Potretzke
- Vignesh Packiam
- Vidit Sharma
- Amir Toussi
- Tanner S. Miest
- and others
Cited in Scopus: 9To better understand the safety and diagnostic yield of percutaneous core-needle biopsy (PCNB) for upper tract urothelial carcinoma (UTUC). - Oncology
The Safety and Short-term Outcomes of Leukocyte Depleted Autologous Transfusions During Radical Cystectomy
UrologyVol. 135p106–110Published online: October 16, 2019- John M Myrga
- Omar M Ayyash
- Jathin Bandari
- Mina M Fam
- Liam C Macleod
- Bruce L Jacobs
- and others
Cited in Scopus: 3To examine long- and short-term outcomes using cell salvage with a commercially available leukocyte depletion filter following radical cystectomy in an oncologic population. - Oncology
Selective Arterial Embolization for Large or Symptomatic Renal Angiomyolipoma: 10 Years of Follow-up
UrologyVol. 135p82–87Published online: October 13, 2019- Omer Anis
- Uri Rimon
- Jacob Ramon
- Boris Khaitovich
- Dorit E. Zilberman
- Orith Portnoy
- and others
Cited in Scopus: 12To assess long-term outcome after selective arterial embolization (SAE) as first-line treatment for large or symptomatic AML. - Oncology
Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery
UrologyVol. 135p88–94Published online: October 1, 2019- Daniel D. Shapiro
- Shane A. Wells
- Sara L. Best
- Sean P. Hedican
- Timothy J. Ziemlewicz
- Meghan G. Lubner
- and others
Cited in Scopus: 16To compare perioperative and oncologic outcomes for patients with clinical T1b renal cell carcinoma following treatment with microwave ablation (MW), partial nephrectomy (PN), or radical nephrectomy (RN). - Oncology
Persistent Discordance in Grade, Stage, and NCCN Risk Stratification in Men Undergoing Targeted Biopsy and Radical Prostatectomy
UrologyVol. 135p117–123Published online: September 27, 2019- Mark N. Alshak
- Neal Patel
- Michael D. Gross
- Daniel Margolis
- Jim C. Hu
Cited in Scopus: 12To elucidate the accuracy of MRI and MRI-ultrasound fusion guided targeted biopsy (TBx) on risk stratification in men who underwent subsequent radical prostatectomy (RP). - Oncology
Kidney Graft Urothelial Carcinoma: Results From a Multicentric Retrospective National Study
UrologyVol. 135p101–105Published online: September 24, 2019- Grégoire Leon
- Nicolas Szabla
- Romain Boissier
- Marc Gigante
- Kevin Caillet
- Gregory Verhoest
- and others
Cited in Scopus: 4To calculate the incidence of renal graft urothelial carcinoma in renal transplant recipients in a national large retrospective cohort and to analyze circumstances of diagnosis, treatment and outcome. - Oncology
Inferior Vena Cava Resection and Reconstruction with Bovine Pericardium for Renal Cell Carcinoma: Complications and Outcomes
UrologyVol. 134p143–147Published online: September 19, 2019- Paul David Morris
- Ruelan Furtado
- Carlo Pulitano
- Michael Crawford
- David Yeo
- Arthur Vasilaras
- and others
Cited in Scopus: 6To assess the postoperative complication rate and overall survival when bovine pericardium is used as graft material for inferior vena cava (IVC) reconstructions in patients with renal cell carcinoma (RCC). The ideal graft material is yet to be established, with synthetic grafts widely studied and used in the current literature. - Oncology
Pathological Characteristics of Prostate Cancer Occurring in Younger Men: A Retrospective Study of Prostatectomy Patients
UrologyVol. 134p163–167Published online: September 18, 2019- James Macneil
- Fiona Maclean
- Warick Delprado
Cited in Scopus: 2To determine if differences exist in the pathological characteristics of prostate cancer occurring in younger men as compared to the disease when it occurs in older men.